Eric Amante

795 total citations
7 papers, 417 citations indexed

About

Eric Amante is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Eric Amante has authored 7 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Eric Amante's work include Rheumatoid Arthritis Research and Therapies (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Eric Amante is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Eric Amante collaborates with scholars based in Australia, Argentina and Philippines. Eric Amante's co-authors include Patrick Durez, Bernardo A. Pons‐Estel, Melvin Churchill, Ingrid Strusberg, Won Park, Roy Fleischmann, Peter Nash, Elizabeth C. Hsia, Paul Emery and Mittie K. Doyle and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Care & Research.

In The Last Decade

Eric Amante

7 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Amante Australia 5 361 193 113 100 65 7 417
E. C. Hsia United States 5 481 1.3× 265 1.4× 126 1.1× 140 1.4× 69 1.1× 34 546
Jeffrey Box United States 3 336 0.9× 177 0.9× 112 1.0× 137 1.4× 58 0.9× 5 445
Ayanbola Elegbe United States 8 308 0.9× 142 0.7× 104 0.9× 116 1.2× 80 1.2× 22 424
Zhiyu Ge United States 4 465 1.3× 226 1.2× 134 1.2× 148 1.5× 111 1.7× 5 582
Ravi Rao United Kingdom 5 184 0.5× 66 0.3× 102 0.9× 109 1.1× 58 0.9× 8 336
B. Combe France 5 309 0.9× 145 0.8× 60 0.5× 107 1.1× 65 1.0× 15 347
M. Chartier France 11 264 0.7× 78 0.4× 85 0.8× 43 0.4× 80 1.2× 44 334
H-P Tony Germany 9 242 0.7× 69 0.4× 56 0.5× 174 1.7× 43 0.7× 23 381
Irina Lazariciu United States 7 224 0.6× 119 0.6× 53 0.5× 73 0.7× 33 0.5× 13 342
Gerd R. Burmester Germany 3 172 0.5× 52 0.3× 53 0.5× 148 1.5× 48 0.7× 4 301

Countries citing papers authored by Eric Amante

Since Specialization
Citations

This map shows the geographic impact of Eric Amante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Amante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Amante more than expected).

Fields of papers citing papers by Eric Amante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Amante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Amante. The network helps show where Eric Amante may publish in the future.

Co-authorship network of co-authors of Eric Amante

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Amante. A scholar is included among the top collaborators of Eric Amante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Amante. Eric Amante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Amante, Eric, et al.. (2022). Erasmus Syndrome: A Case Report and Literature Review. American Journal of Case Reports. 23. e937061–e937061. 5 indexed citations
2.
Emery, Paul, Roy Fleischmann, Ingrid Strusberg, et al.. (2015). Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial. Arthritis Care & Research. 68(6). 744–752. 34 indexed citations
3.
Emery, Paul, Roy Fleischmann, Ingrid Strusberg, et al.. (2014). 97. Final 5-Year Safety and Efficacy Results of a Phase 3, Randomized, Placebo-Controlled Trial of Golimumab in Methotrexate-NaïVe Patients with Rheumatoid Arthritis. Lara D. Veeken. 53(suppl_1). i93–i93. 3 indexed citations
4.
5.
Emery, Paul, R Fleischmann, Ingrid Strusberg, et al.. (2013). FRI0178 Five-year safety and efficacy of golimumab in methotrexate-naïve patients with rheumatoid arthritis: final study results of the phase 3, randomized, placebo-controlled go-before trial. Annals of the Rheumatic Diseases. 72. A432–A432. 2 indexed citations
6.
7.
Fleischmann, R, Patrick Durez, P. Emery, et al.. (2008). Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study. DIAL (Catholic University of Leuven). 58(9). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. C. Hsia Breakdown of academic impact, for papers by Jeffrey Box Breakdown of academic impact, for papers by Ayanbola Elegbe Breakdown of academic impact, for papers by Zhiyu Ge Breakdown of academic impact, for papers by Ravi Rao Breakdown of academic impact, for papers by B. Combe Breakdown of academic impact, for papers by M. Chartier Breakdown of academic impact, for papers by H-P Tony Breakdown of academic impact, for papers by Irina Lazariciu Breakdown of academic impact, for papers by Gerd R. Burmester
Rankless by CCL
2026